Hasil Pencarian - Zabransky M
- Menampilkan 1 - 7 hasil dari 7
-
1
Ten years of biosimilars in Europe: development and evolution of the regulatory pathways oleh Schiestl M, Zabransky M, Sörgel F
Diterbitkan 2017-05-01Dapatkan teks lengkap
Artikel -
2
Acceptability of the reusable SurePal™ self-injection device for Omnitrope® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter obs... oleh Partsch CJ, Schnabel D, Ehtisham S, Johnstone HC, Zabransky M, Kiess W
Diterbitkan 2015-09-01Dapatkan teks lengkap
Artikel -
3
Ten years of clinical experience with biosimilar human growth hormone: a review of safety data oleh Borrás Pérez MV, Kriström B, Romer T, Walczak M, Höbel N, Zabransky M
Diterbitkan 2017-05-01Dapatkan teks lengkap
Artikel -
4
Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data oleh López-Siguero JP, Pfäffle R, Chanson P, Szalecki M, Höbel N, Zabransky M
Diterbitkan 2017-05-01Dapatkan teks lengkap
Artikel -
5
Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observation... oleh Schnabel D, Partsch CJ, Houang M, Ehtisham S, Johnstone H, Zabransky M, Kiess W
Diterbitkan 2016-09-01Dapatkan teks lengkap
Artikel -
6
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an Internation... oleh Loche S, Kanumakala S, Backeljauw P, Schwab KO, Lechuga-Sancho AM, Esmael A, Urosevic D, Boldea A, Zabransky M
Diterbitkan 2024-03-01Dapatkan teks lengkap
Artikel -
7
Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study oleh Rapaport R, Saenger P, Schmidt H, Hasegawa Y, Colle M, Loche S, Marcantonio S, Bonfig W, Zabransky M, Lifshitz F
Diterbitkan 2013-09-01Dapatkan teks lengkap
Artikel